文献速递心脑血管急症重症综合管理与镇静镇痛

自发性脑出血微创清除术后残留或治疗结束时血肿负荷的系统评价与预后因素Meta分析

Systematic Review and Prognostic-Factor Meta-analysis of Residual or End-of-Treatment Hematoma Burden after Minimally Invasive Evacuation for Spontaneous Intracerebral Hemorrhage.
PubMed 文献 · Neurocrit Care · 2026-10-28
一句话结论残留/治疗结束时血肿体积每增加1 mL,功能预后良好odds方向性降低但主要估计跨无效线(OR 0.946,95%CI 0.879-1.018),现有证据不支持通用 cutoff 或因果治疗目标。

该系统评价与预后因素Meta分析检索Embase、Web of Science、Cochrane Library和PubMed(截至2026年5月10日,无语言/年份限制),纳入成人自发性脑出血接受微创清除术、且报告残留/治疗结束时血肿负荷与临床结局关系的研究。881条记录中62篇定性纳入,仅3项独立研究进入探索性连续模型。每1 mL残留/治疗结束时血肿体积增加与功能预后良好odds降低呈方向性关联,但主要估计未达统计学显著(OR 0.946,95%CI 0.879-1.018;k=3;近似预测区间0.69-1.29);DL/Wald敏感性分析OR 0.944(95%CI 0.914-0.976)。mRS 0-3分析仅2项研究,异质性阈值证据未合并。当前证据不能验证通用cutoff或因果治疗目标。

要点

  • 每1 mL残留/治疗结束时血肿体积增加,功能预后良好odds方向性降低,但主要估计跨无效线(OR 0.946,95%CI 0.879-1.018;k=3),不能据此设定床旁体积目标。
  • 仅3项独立研究进入探索性连续Meta分析,样本与证据基础很小,残留/治疗结束时体积与结局的关联需前瞻性验证。
  • DL/Wald敏感性分析OR 0.944(95%CI 0.914-0.976),与主要推断(REML+Hartung-Knapp调整)结论方向一致但显著性不同,解读需谨慎。
  • 异质性阈值证据未合并,mRS 0-3分析仅2项研究,原文明确当前证据不支持通用cutoff或因果治疗目标。
  • 未来试验应统一影像与结局数据元素,以检验治疗结束时体积-结局关联及治疗结束时体积是否可作为技术目标。

适用人群与场景

  • 成人自发性脑出血接受微创清除术的患者,且研究报告残留或治疗结束时血肿负荷与临床结局的关系。
  • 原文未提及具体排除人群、急诊/ICU/院前场景或病情阶段。

诊断标准与关键阈值

  • 原文未提及诊断标准、评分界值或启动/停止阈值。
  • 原文明确当前证据不支持通用cutoff或因果治疗目标。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:系统评价与预后因素Meta分析,检索Embase、Web of Science、Cochrane Library和PubMed(截至2026年5月10日,无语言/年份限制),PROSPERO注册号CRD420261399487。
  • 881条记录中62篇定性纳入;12篇进行定量可提取性审查,10篇提供定量证据或审计行,仅3项独立研究进入探索性连续模型。
  • 每1 mL残留/治疗结束时血肿体积增加与功能预后良好odds降低呈方向性关联,主要估计OR 0.946(95%CI 0.879-1.018;k=3;近似预测区间0.69-1.29),未达统计学显著。
  • DL/Wald敏感性分析OR 0.944(95%CI 0.914-0.976)。
  • mRS 0-3分析纳入2项研究;异质性阈值证据未合并。

证据类型、等级与局限

  • 证据类型:系统评价与预后因素Meta分析(PROSPERO CRD420261399487)。
  • 局限:仅3项独立研究进入探索性连续Meta分析;主要估计跨无效线;阈值证据异质性大未合并;原文指出当前证据不能验证通用cutoff或因果治疗目标。

对床旁实践的改变

  • 不能依据残留/治疗结束时血肿体积设定通用cutoff或将其作为因果治疗目标。
  • 床旁解读残留/治疗结束时血肿体积与功能预后的关系时,需认识到现有证据仅来自3项独立研究的探索性分析,主要估计未达统计学显著。
  • 未来需统一影像与结局数据元素的前瞻性试验来验证治疗结束时体积-结局关联及技术目标价值。

指南或共识出处

  • 原文未提及具体指南或共识名称;本文为系统评价与Meta分析,注册于PROSPERO(CRD420261399487)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVE: Residual or end-of-treatment (EOT) hematoma burden may explain variation in recovery after minimally invasive evacuation for spontaneous intracerebral hemorrhage (ICH). We assessed its association with functional outcome and mortality.

METHODS: Embase, Web of Science, the Cochrane Library, and PubMed were searched through 10 May 2026 without language or year restrictions. Eligible reports enrolled adults with spontaneous ICH treated by minimally invasive evacuation and related residual/EOT burden to clinical outcomes. Adjusted continuous prognostic estimates were prioritized. Random-effects inverse-variance meta-analysis used log odds ratios (ORs), with restricted maximum likelihood and Hartung-Knapp adjustment as primary inference and DerSimonian-Laird (DL)/Wald analysis as sensitivity analysis. Heterogeneous threshold evidence was summarized without a pooled effect. The review was registered in International Prospective Register of Systematic Reviews (PROSPERO; CRD420261399487).

RESULTS: Among 881 records, 62 reports were included qualitatively. Of the reports, 12 underwent quantitative extractability review, 10 contributed quantitative evidence or audit rows, and 3 independent studies entered the exploratory continuous model. Each 1 mL greater residual/EOT volume was directionally associated with lower odds of favorable functional outcome, but the primary estimate crossed the null [OR 0.946, 95% confidence interval (CI) 0.879-1.018; k = 3; approximate prediction interval 0.69-1.29]. The DL/Wald sensitivity estimate was OR 0.944 (95% CI 0.914-0.976). The modified Rankin Scale (mRS) 0-3 analysis included two studies, and heterogeneous threshold evidence was not pooled.

CONCLUSIONS: Only three independent studies informed the exploratory continuous meta-analysis. Smaller residual/EOT volume was directionally associated with better functional outcome, but the primary estimate was not statistically significant (OR 0.946, 95% CI 0.879-1.018). Future trials should use common imaging and outcome data elements to test EOT volume-outcome associations and whether EOT volume is useful as a technical target; current evidence does not validate a universal cutoff or causal treatment target.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Guo C, Zhang C, Zhang XB, et al. Systematic Review and Prognostic-Factor Meta-analysis of Residual or End-of-Treatment Hematoma Burden after Minimally Invasive Evacuation for Spontaneous Intracerebral Hemorrhage. Neurocrit Care. 2026. PMID: 42955701. doi:10.1007/s12028-026-02703-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。